NVS logo

Novartis AG (NVS) Gross profit

Annual gross profit:

$37.48B+$4.61B(+14.04%)
December 31, 2024

Summary

  • As of today (August 22, 2025), NVS annual gross profit is $37.48 billion, with the most recent change of +$4.61 billion (+14.04%) on December 31, 2024.
  • During the last 3 years, NVS annual gross profit has risen by +$1.72 billion (+4.81%).
  • NVS annual gross profit is now -4.05% below its all-time high of $39.06 billion, reached on December 31, 2011.

Performance

1-year change

+14.04%

3-year change

+4.81%

5-year change

+13.33%

15-year change

+17.37%

NVS Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

99.5%
NVS annual gross profit is higher than 99.5% of companies in Healthcare sector

Range

All-time high

$39.06B
NVS annual gross profit is currently -4.05% below its historical high of $39.06 billion

3-year low

$30.78B
NVS annual gross profit is currently +21.77% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
NVS previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
NVS next annual earnings announcement has not yet been scheduled

OtherNVSincome statement metrics

annual gross margin

74.53%
NVS annual gross profit margin is 74.53%

Annual revenue

$50.29B
NVS annual revenue is $50.29 billion

annual net income

$11.93B
NVS annual net profit is $11.93 billion

Annual EPS

$5.92
NVS annual earnings per share is $5.92

quarterly gross profit:

$10.91B+$969.37M(+9.75%)
June 30, 2025

Summary

  • As of today (August 22, 2025), NVS quarterly gross profit is $10.91 billion, with the most recent change of +$969.37 million (+9.75%) on June 30, 2025.
  • Over the past year, NVS quarterly gross profit has increased by +$1.61 billion (+17.35%).
  • NVS quarterly gross profit is now -1.70% below its all-time high of $11.10 billion, reached on June 30, 2011.

Performance

3-month change

+9.75%

1-year change

+17.35%

3-year change

+20.79%

5-year change

+37.75%

NVS quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

99.47%
NVS quarterly gross profit is higher than 99.47% of companies in Healthcare sector

Range

All-time high

$11.10B
NVS quarterly gross profit is currently -1.70% below its historical high of $11.10 billion

3-year low

$7.62B
NVS quarterly gross profit is currently +43.18% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
NVS previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
NVS next earnings announcement is scheduled for Oct 28, 2025

OtherNVSincome statement metrics

quarterly gross margin

76.38%
NVS quarterly gross profit margin is 76.38%

Quarterly revenue

$14.28B
NVS quarterly revenue is $14.28 billion

quarterly net income

$4.09B
NVS quarterly net profit is $4.09 billion

Quarterly EPS

$2.10
NVS quarterly earnings per share is $2.10

TTM gross profit:

$40.12B+$1.61B(+4.19%)
June 30, 2025

Summary

  • As of today (August 22, 2025), NVS TTM gross profit is $40.12 billion, with the most recent change of +$1.61 billion (+4.19%) on June 30, 2025.
  • Over the past year, NVS TTM gross profit has increased by +$5.28 billion (+15.14%).
  • NVS TTM gross profit is now -4.52% below its all-time high of $42.02 billion, reached on September 30, 2011.

Performance

3-month change

+4.19%

1-year change

+15.14%

3-year change

+11.24%

5-year change

+20.54%

NVS TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

99.38%
NVS TTM gross profit is higher than 99.38% of companies in Healthcare sector

Range

All-time high

$42.02B
NVS TTM gross profit is currently -4.52% below its historical high of $42.02 billion

3-year low

$31.22B
NVS TTM gross profit is currently +28.50% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
NVS previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 28, 2025
NVS next earnings announcement is scheduled for Oct 28, 2025

OtherNVSincome statement metrics

annual gross margin

74.53%
NVS annual gross profit margin is 74.53%

TTM revenue

$53.40B
NVS TTM revenue is $53.40 billion

TTM net income

$13.68B
NVS TTM net profit is $13.68 billion

TTM EPS

$6.92
NVS TTM earnings per share is $6.92

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

Annual gross profit

$37.48B
NVS annual gross profit is $37.48 billion

Annual revenue

$50.29B
NVS annual revenue is $50.29 billion

annual cost of goods sold

$12.81B
NVS annual cost of goods sold is $12.81 billion

NVS Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+14.0%+17.4%+15.1%
3 y3 years+4.8%+20.8%+11.2%
5 y5 years+13.3%+37.8%+20.5%

NVS Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+21.8%at high+43.2%at high+28.5%
5 y5-yearat high+21.8%at high+43.2%at high+28.5%
alltimeall time-4.0%+162.0%-1.7%>+9999.0%-4.5%>+9999.0%

NVS Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$10.91B(+9.8%)
$40.12B(+4.2%)
Mar 2025
-
$9.94B(+1.8%)
$38.51B(+3.3%)
Dec 2024
$37.48B(+14.0%)
$9.76B(+2.5%)
$37.27B(+3.9%)
Sep 2024
-
$9.52B(+2.4%)
$35.87B(+2.9%)
Jun 2024
-
$9.29B(+6.9%)
$34.85B(+3.6%)
Mar 2024
-
$8.70B(+4.1%)
$33.64B(+2.7%)
Dec 2023
$32.87B(+6.8%)
$8.36B(-1.6%)
$32.77B(+2.1%)
Sep 2023
-
$8.50B(+5.0%)
$32.10B(+2.8%)
Jun 2023
-
$8.09B(+3.4%)
$31.22B(-2.9%)
Mar 2023
-
$7.83B(+1.7%)
$32.16B(-2.6%)
Dec 2022
$30.78B(-13.9%)
$7.69B(+1.0%)
$33.01B(-4.5%)
Sep 2022
-
$7.62B(-15.6%)
$34.58B(-4.1%)
Jun 2022
-
$9.03B(+4.1%)
$36.07B(-0.0%)
Mar 2022
-
$8.68B(-6.3%)
$36.08B(+0.8%)
Dec 2021
$35.76B(+6.6%)
$9.25B(+1.6%)
$35.78B(+2.0%)
Sep 2021
-
$9.11B(+0.7%)
$35.08B(+1.7%)
Jun 2021
-
$9.04B(+8.0%)
$34.47B(+3.4%)
Mar 2021
-
$8.37B(-2.1%)
$33.35B(-0.6%)
Dec 2020
$33.54B(+1.4%)
$8.55B(+0.6%)
$33.54B(+0.4%)
Sep 2020
-
$8.51B(+7.4%)
$33.40B(+0.3%)
Jun 2020
-
$7.92B(-7.5%)
$33.29B(-1.3%)
Mar 2020
-
$8.56B(+1.8%)
$33.73B(+2.0%)
Dec 2019
$33.07B(+9.1%)
$8.41B(+0.2%)
$33.07B(+2.9%)
Sep 2019
-
$8.40B(+0.5%)
$32.13B(+2.6%)
Jun 2019
-
$8.36B(+5.7%)
$31.31B(+1.8%)
Mar 2019
-
$7.91B(+5.9%)
$30.75B(+1.4%)
Dec 2018
$30.32B(-5.0%)
$7.46B(-1.5%)
$30.32B(-3.1%)
Sep 2018
-
$7.58B(-2.8%)
$31.29B(-1.6%)
Jun 2018
-
$7.80B(+4.3%)
$31.79B(-0.6%)
Mar 2018
-
$7.48B(-11.3%)
$31.98B(+0.1%)
Dec 2017
$31.93B(+3.0%)
$8.43B(+4.2%)
$31.93B(+1.9%)
Sep 2017
-
$8.09B(+1.3%)
$31.34B(+1.1%)
Jun 2017
-
$7.98B(+7.4%)
$31.01B(-0.1%)
Mar 2017
-
$7.43B(-5.1%)
$31.04B(+0.1%)
Dec 2016
$31.00B(-3.2%)
$7.83B(+1.0%)
$31.00B(-0.4%)
Sep 2016
-
$7.76B(-3.3%)
$31.14B(-0.4%)
Jun 2016
-
$8.02B(+8.5%)
$31.25B(-0.6%)
Mar 2016
-
$7.39B(-7.3%)
$31.44B(-1.9%)
Dec 2015
$32.04B(-8.7%)
$7.97B(+1.2%)
$32.04B(-2.3%)
Sep 2015
-
$7.88B(-4.0%)
$32.78B(-2.2%)
Jun 2015
-
$8.21B(+2.8%)
$33.53B(-2.9%)
Mar 2015
-
$7.98B(-8.4%)
$34.53B(-4.3%)
Dec 2014
$35.07B(-1.2%)
$8.71B(+1.0%)
$36.08B(-0.8%)
Sep 2014
-
$8.63B(-6.3%)
$36.38B(-0.0%)
Jun 2014
-
$9.21B(-3.5%)
$36.38B(+0.4%)
Mar 2014
-
$9.54B(+5.8%)
$36.22B(+1.5%)
Dec 2013
$35.51B(-6.1%)
$9.01B(+4.5%)
$35.70B(-2.0%)
Sep 2013
-
$8.63B(-4.6%)
$36.43B(-0.7%)
Jun 2013
-
$9.04B(+0.3%)
$36.69B(-0.6%)
Mar 2013
-
$9.02B(-7.5%)
$36.90B(+0.7%)
Dec 2012
$37.83B
$9.74B(+9.6%)
$36.65B(+1.2%)
Sep 2012
-
$8.89B(-3.9%)
$36.20B(-5.2%)
Jun 2012
-
$9.25B(+5.5%)
$38.18B(-4.6%)
DateAnnualQuarterlyTTM
Mar 2012
-
$8.77B(-5.6%)
$40.03B(-2.3%)
Dec 2011
$39.06B(+9.2%)
$9.29B(-14.5%)
$40.98B(-2.5%)
Sep 2011
-
$10.87B(-2.0%)
$42.02B(+5.2%)
Jun 2011
-
$11.10B(+14.1%)
$39.95B(+8.9%)
Mar 2011
-
$9.72B(-5.9%)
$36.68B(+3.4%)
Dec 2010
$35.77B(+16.7%)
$10.33B(+17.4%)
$35.46B(+1.5%)
Sep 2010
-
$8.80B(+12.5%)
$34.93B(+2.6%)
Jun 2010
-
$7.82B(-8.0%)
$34.05B(+0.3%)
Mar 2010
-
$8.50B(-13.3%)
$33.96B(+4.2%)
Dec 2009
$30.64B(+2.1%)
$9.80B(+23.8%)
$32.58B(+8.5%)
Sep 2009
-
$7.92B(+2.5%)
$30.02B(+0.2%)
Jun 2009
-
$7.73B(+8.5%)
$29.95B(-0.3%)
Mar 2009
-
$7.12B(-1.6%)
$30.04B(+0.2%)
Dec 2008
$30.02B(+8.5%)
$7.24B(-7.8%)
$29.96B(+1.1%)
Sep 2008
-
$7.85B(+0.5%)
$29.64B(+0.9%)
Jun 2008
-
$7.81B(+10.8%)
$29.37B(+3.1%)
Mar 2008
-
$7.05B(+1.9%)
$28.49B(+0.5%)
Dec 2007
$27.68B(+10.5%)
$6.92B(-8.8%)
$28.34B(+0.7%)
Sep 2007
-
$7.59B(+9.5%)
$28.14B(+3.9%)
Jun 2007
-
$6.93B(+0.4%)
$27.07B(+1.9%)
Mar 2007
-
$6.90B(+2.7%)
$26.57B(+3.8%)
Dec 2006
$25.05B(+8.9%)
$6.72B(+3.0%)
$25.61B(+4.4%)
Sep 2006
-
$6.53B(+1.5%)
$24.52B(+1.3%)
Jun 2006
-
$6.43B(+8.2%)
$24.21B(+2.8%)
Mar 2006
-
$5.94B(+5.5%)
$23.56B(+2.2%)
Dec 2005
$23.01B(+9.8%)
$5.63B(-9.5%)
$23.05B(-0.6%)
Sep 2005
-
$6.22B(+7.8%)
$23.20B(+3.9%)
Jun 2005
-
$5.77B(+6.2%)
$22.32B(+1.8%)
Mar 2005
-
$5.43B(-5.9%)
$21.93B(+0.5%)
Dec 2004
$20.96B(+10.5%)
$5.77B(+7.9%)
$21.83B(+2.5%)
Sep 2004
-
$5.35B(-0.6%)
$21.29B(+3.1%)
Jun 2004
-
$5.38B(+0.9%)
$20.66B(+1.8%)
Mar 2004
-
$5.33B(+1.8%)
$20.30B(+3.5%)
Dec 2003
$18.97B(+16.5%)
$5.24B(+11.1%)
$19.62B(+6.1%)
Sep 2003
-
$4.71B(-6.1%)
$18.50B(+3.5%)
Jun 2003
-
$5.02B(+8.0%)
$17.87B(+6.1%)
Mar 2003
-
$4.65B(+13.0%)
$16.84B(+38.1%)
Dec 2002
$16.28B(+13.8%)
$4.12B(+0.7%)
$12.19B(+51.0%)
Sep 2002
-
$4.09B(+2.4%)
$8.08B(+102.4%)
Jun 2002
-
$3.99B(>+9900.0%)
$3.99B(>+9900.0%)
Mar 2002
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2001
$14.30B(-5.8%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2001
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2001
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2001
-
$0.00(0.0%)
$3.22B(0.0%)
Dec 2000
$15.19B(+0.9%)
$0.00(-100.0%)
$3.22B(0.0%)
Jun 2000
-
$3.22B
$3.22B
Dec 1999
$15.05B(+0.8%)
-
-
Dec 1998
$14.94B(+1.6%)
-
-
Dec 1997
$14.71B(-14.0%)
-
-
Dec 1996
$17.10B(-2.6%)
-
-
Dec 1995
$17.56B(+11.2%)
-
-
Dec 1994
$15.78B(+7.2%)
-
-
Dec 1993
$14.73B
-
-

FAQ

  • What is Novartis AG annual gross profit?
  • What is the all time high annual gross profit for Novartis AG?
  • What is Novartis AG annual gross profit year-on-year change?
  • What is Novartis AG quarterly gross profit?
  • What is the all time high quarterly gross profit for Novartis AG?
  • What is Novartis AG quarterly gross profit year-on-year change?
  • What is Novartis AG TTM gross profit?
  • What is the all time high TTM gross profit for Novartis AG?
  • What is Novartis AG TTM gross profit year-on-year change?

What is Novartis AG annual gross profit?

The current annual gross profit of NVS is $37.48B

What is the all time high annual gross profit for Novartis AG?

Novartis AG all-time high annual gross profit is $39.06B

What is Novartis AG annual gross profit year-on-year change?

Over the past year, NVS annual gross profit has changed by +$4.61B (+14.04%)

What is Novartis AG quarterly gross profit?

The current quarterly gross profit of NVS is $10.91B

What is the all time high quarterly gross profit for Novartis AG?

Novartis AG all-time high quarterly gross profit is $11.10B

What is Novartis AG quarterly gross profit year-on-year change?

Over the past year, NVS quarterly gross profit has changed by +$1.61B (+17.35%)

What is Novartis AG TTM gross profit?

The current TTM gross profit of NVS is $40.12B

What is the all time high TTM gross profit for Novartis AG?

Novartis AG all-time high TTM gross profit is $42.02B

What is Novartis AG TTM gross profit year-on-year change?

Over the past year, NVS TTM gross profit has changed by +$5.28B (+15.14%)
On this page